Company: GANX
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001558370-25-007747
Chunk: 4

Company: Gain Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 4
---
Item 1. Condensed Consolidated Financial Statements.

​

PART I—FINANCIAL INFORMATION

​

GAIN THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

​​​​​​​​ ​        March 31,     December 31, ​​​2025​2024Assets  ​   ​  Current assets:  ​   ​  Cash and cash equivalents ​$ 9,070,102​$ 10,385,863Tax credits​​​ 247,656​​ 271,079Prepaid expenses and other current assets ​  1,833,659​  945,536Total current assets ​​ 11,151,417​​ 11,602,478​​​​​​​​Noncurrent assets: ​   ​   Property and equipment, net ​  97,509​  103,619Internal-use software, net​​​ 126,291​​ 134,268Operating lease right-of-use assets ​  183,664​  219,715Restricted cash ​  32,542​  31,695Long-term deposits and other noncurrent assets ​  32,641​  32,109Total noncurrent assets ​​ 472,647​​ 521,406Total assets ​$ 11,624,064​$ 12,123,884​​​​​​​​Liabilities and stockholders' equity​​​​​​​Current liabilities: ​   ​   Accounts payable ​$ 2,151,410​$ 946,259Operating lease liability - current ​  148,674​  160,913Other current liabilities ​  2,397,386​  2,441,761Deferred grant income - current ​  217,841​  252,211Loans - current ​​ 113,121​​ 110,177Total current liabilities ​​ 5,028,432​​ 3,911,321​​​​​​​​Noncurrent liabilities: ​   ​   Defined benefit pension plan ​​ 470,856​​ 443,623Operating lease liability - noncurrent ​  30,589​  53,598Deferred grant income - noncurrent​​​ —​​ 47,441Loans - noncurrent ​​ 314,476​​